A Blueprint for A Successful Capital Raising Using REG Offerings
DISRUPTION OF PRIVATE SECURITIES
The Democratization of Capital
Regulation A provides a vehicle for companies to raise up to $75 million per year from both accredited and non-accredited (“Main Street”) investors. This is made possible through the 2012 JOBS Act, which changed reporting and disclosure requirements for small and medium sized businesses.
Previously, they were restricted to either Venture Captial or onerous Regulation D offerings for growth capital. Regulation A provides capital-intensive life sciences companies with a viable alternative funding strategy. Read about the company that raised $60 million using Reg A+.
HOW WE HELP COMPANIES
CAPITAL PLANNING VALUATION STRATEGY™
Capital Planning Valuation Strategy™ (CPVS™) is our proprietary 6-week process designed to help business owners decide whether a Regulation A offering is right for them. CPVS™ provides a path to maintain control of your company through multiple cycles of fundraising while building a blueprint for a successful Regulation A Offering. Learn more about how a CPVS™ can help your business unlock growth capital today.
Learn More About CPVS™ ProcessClient Testimonials
CPVS™ is the best capital raising analytics service on the market, and it’s the only one tailored specifically to healthcare companies like yours. But don’t just take our word for it…
“Medical Funding Professionals’ comprehensive approach to capital planning has been instrumental in shaping our fundraising strategy. The 1.5-hour presentation they delivered was particularly beneficial as it outlined several funding paths that could save us time and money compared to more conventional routes. Just as important, the strategies they proposed were tailored specifically to our funding needs and goals, resulting in a customized plan that exceeded our expectations.
We are now much better prepared to make capital raising decisions. I would recommend Medical Funding Professionals and their CPVS™ Process to any business owner or organization looking to raise capital.”
Curtis Rhine
CFO, RS BioTherapeutics
“Since launching Manhattan Stret Capital in 2015, I’ve worked with hundreds of companies wanting to raise capital, and the fact of the matter is, most of them simply aren’t prepared—not that their business isn’t a good candidate for raising money, but they just aren’t ready in terms of founder knowledge, corporate organization, capitalization, presentation, and marketing.
That’s why I’m very impressed by what Stephen Brock has brought to the table. His Capital Planning Valuation Strategy™ is a systematic, progressive approach following the best practices of capital raising. He invests the time in educating them on corporate structure, the various types of fundraising opportunities and what’s appropriate for them. Understanding securities is complex, and Stephen has a wealth of knowledge to share with founders.”
Rod Turner
CEO, Manhattan Street Capital
Industry Leading Partners
CPVS™ gives you an extensive network of partners to guide you through a successful Reg A Offering . You will have access to the legal, compliance, marketing, and technology resources from industry leaders.
Ready to Raise Funds?
MedTech and Fundraising News
The latest on Regulation A , life sciences innovation, and the democritization of capital.
How to Choose the Right Funding Strategy for Your Startup
Whether you’re developing a revolutionary app or launching a groundbreaking product, having the right funding strategy is essential to fuel your growth and turn your ideas into reality. In this blog post, we will explore the various fundraising options available to startups and provide guidance on how to choose the one that best aligns with your business goals and objectives.
Read moreWhy do I need a FINRA Broker-Dealer?
Broker-dealers are an important element of the fundraising process, and selecting the right one is crucial to your success. Some states require issuers to work with a broker-dealer.
Read moreDigital Surgery 4.0 and The Power of Go, Go, Go
The LSI Blog features an interview with Scott Huennekens, the keynote speaker at the 2021 Emerging Medtech Summit, discussing his career, his “Go, go, go” philosophy.
Read more